Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

17
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating Titanium Fastener Technology: Results from the Multi-center Prospective CRIMP Study.

Advances in therapy·2026
Same author

Editorial: Bioresorbable materials: What is new?

Frontiers in bioengineering and biotechnology·2026
Same author

Apoptosis execution is spatially regulated.

Apoptosis : an international journal on programmed cell death·2026
Same author

Beyond wellness: modeling the impact of organizational physical activity climate on job performance through psychological and behavioral pathways.

Frontiers in psychology·2026
Same author

Differences in clinical presentation between heart failure patients with reduced and preserved ejection fraction - analysis of the INTELHEART database.

Acta cardiologica·2026
Same author

Association of Coronary Artery Calcium Score with Cardiovascular Outcomes in Patients Without Known Coronary Artery Disease.

Life (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jul 26, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K

Machine learning and physical based modeling for cardiac hypertrophy.

Bogdan Milićević1,2, Miljan Milošević2,3,4, Vladimir Simić2,3

  • 1Faculty of Engineering, University of Kragujevac, Kragujevac 34000, Serbia.

Heliyon
|June 14, 2023
PubMed
Summary

Machine learning and finite element models predict cardiac hypertrophy progression over six years, offering valuable clinical insights. Machine learning models are faster and more suitable for clinical practice.

Keywords:
Cardiac hypertrophyDisease progress trackingFinite element analysisLeft ventricle modeMachine learning

More Related Videos

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.5K
Patient-specific Modeling of the Heart: Estimation of Ventricular Fiber Orientations
12:09

Patient-specific Modeling of the Heart: Estimation of Ventricular Fiber Orientations

Published on: January 8, 2013

13.7K

Related Experiment Videos

Last Updated: Jul 26, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.5K
Patient-specific Modeling of the Heart: Estimation of Ventricular Fiber Orientations
12:09

Patient-specific Modeling of the Heart: Estimation of Ventricular Fiber Orientations

Published on: January 8, 2013

13.7K

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Computational Biology

Background:

  • Predicting left ventricular remodeling and expansion in patients is clinically significant but challenging.
  • Cardiac hypertrophy, a condition of left ventricular enlargement, requires accurate long-term monitoring.

Purpose of the Study:

  • To develop and compare machine learning (ML) and physics-based (finite element) models for predicting cardiac hypertrophy.
  • To assess the accuracy and speed of ML and finite element models in forecasting disease evolution.

Main Methods:

  • Trained ML models (random forests, gradient boosting, neural networks) using patient medical history and cardiac health data.
  • Developed a physics-based finite element model simulating cardiac hypertrophy development.
  • Collected multi-patient data for model training and validation.

Main Results:

  • Both ML and finite element models accurately forecasted hypertrophy evolution over six years, showing similar outcomes.
  • The finite element model demonstrated higher accuracy due to its basis in physical laws.
  • The ML model exhibited significantly faster computation times.

Conclusions:

  • ML models offer a faster, potentially clinically applicable approach for monitoring cardiac hypertrophy.
  • Finite element models provide greater accuracy but are computationally intensive.
  • Integrating finite element simulation data into ML models can enhance speed and accuracy for clinical use.